| Project/Area Number |
13470245
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Tokyo Women's Medical University |
|---|
Principal Investigator |
KIMIKAWA Masaaki Tokyo Women's Medical University, Surgery III, Assistant, 医学部, 助手 (70204964)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NAKAMURA Michio Tokyo Women's Medical University, Surgery III, Assistant, 医学部, 助手 (00246547)
SATO Yuichi Tokyo Women's Medical University, Surgery III, Assistant, 医学部, 助手 (80231348)
TERAOKA Satoshi Tokyo Women's Medical University, Surgery III, Professor, 医学部, 教授 (20147383)
KAWASE Tomonori Tokyo Women's Medical University, Surgery III, Assistant, 医学部, 助手 (00307555)
石井 保夫 東京女子医科大学, 医学部, 助手 (80318039)
|
|---|
| Project Period (FY) |
2001 – 2002
|
| Project Status |
Completed (Fiscal Year 2002)
|
| Budget Amount *help |
¥13,900,000 (Direct Cost: ¥13,900,000)
Fiscal Year 2002: ¥6,700,000 (Direct Cost: ¥6,700,000)
Fiscal Year 2001: ¥7,200,000 (Direct Cost: ¥7,200,000)
|
|---|
| Keywords | Transplantation / tolerance / apoptosis in lymphocytes / kidney transplantation / FTY720 / peripheral blood stem cell transplantation |
|---|
| Research Abstract |
(Background) We previously demonstrated that a nonmyeloablative, T-cell depleting preparative regimen including whole-body irradiation, thymic irradiation and donor bone marrow infusion induced mixed chimerism and allograft tolerance. Although tolerance has been successfully induced in the majority of recipients treated with this approach, broad clinical application requires simplifying the therapeutic regimen.
(Methods) Male rhesus monkeys weighing 4-7 kg were used. T-cell depletion was planned using a combination of cyclophosphamide (CY) and the novel agent, FTY720 without irradiation. A second modification was allotransplantation of granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSCs), which has been increasingly used clinically as an alternative to allogeneic bone marrow transplantation.
(Results) In 3 of 5 recipients in full protocol, renal function remained stable with no evidence of rejection more than 300 days after discontinuing immunosuppressive therapy. Donor-specific hyporesponsiveness was confirmed by sequential in vitro mixed lymphocyte reactions as well as skin transplantation from the original kidney donor in 1 recipient. The donor skin was accepted, while third party skin was rejected.
(Conclusions) The mechanisms involved in the long-term immunosuppression-free allograft survival observed here remain to be elucidated. Nevertheless, these encouraging preliminary observations suggest that this approach to tolerance induction is particularly applicable to clinical protocols because of the non-toxic, relatively uncomplicated conditioning regimen required.
|
